Scientists develop a potential antibiotic from Komodo dragon blood

  29 October 2020

Komodo dragon blood may hold the key to tackling the “looming crisis” of antimicrobial resistance, according to scientists behind a potential new antibiotic, DRGN-6.

The synthetic molecule, developed by experts at George Mason University in the United States, was created by combining two genes found in Komodo dragon blood – an endangered species found on five Indonesian islands. 

In preclinical tests DRGN-6 killed carbapenem-resistant Klebsiella pneumoniae, a highly drug resistant bacteria which causes a particularly aggressive form of pneumonia. 

 

Further reading: The Telegraph
Author(s): Sarah Newey, Jordan Kelly-Linden
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 550 AMR professionals and students in 60 countries!

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
WordPress PopUp Plugin